Guillain-Barré Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical Trial: Temporal Associations Do Not Imply Causality
- PMID: 33824169
- DOI: 10.1212/WNL.0000000000011881
Guillain-Barré Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical Trial: Temporal Associations Do Not Imply Causality
Comment in
-
Quelling Public Fears About Guillain-Barré Syndrome and COVID-19 Vaccination.Neurology. 2021 May 31;96(22):1021-1022. doi: 10.1212/WNL.0000000000011882. Neurology. 2021. PMID: 33824170 No abstract available.
-
Reader Response: Guillain-Barré Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical Trial.Neurology. 2021 Oct 26;97(17):841. doi: 10.1212/WNL.0000000000012732. Neurology. 2021. PMID: 34697213 No abstract available.
-
Author Response: Guillain-Barré Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical Trial.Neurology. 2021 Oct 26;97(17):841-842. doi: 10.1212/WNL.0000000000012733. Neurology. 2021. PMID: 34697214 No abstract available.
Comment on
-
Quelling Public Fears About Guillain-Barré Syndrome and COVID-19 Vaccination.Neurology. 2021 May 31;96(22):1021-1022. doi: 10.1212/WNL.0000000000011882. Neurology. 2021. PMID: 33824170 No abstract available.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources